Glen Harbor Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Glen Harbor Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$290K	Buy	22,372 +680	+3%	+$8.21K	0.01%	898
2019 Q2	$270K	Hold	21,692	–	–	0.01%	929
2019 Q1	$315K	Buy	21,692 +102	+0.5%	+$1.3K	0.01%	849
2018 Q4	$238K	Buy	21,590 +6,596	+44%	+$91.8K	0.01%	892
2018 Q3	$394K	Buy	14,994 +2,108	+16%	+$57K	0.01%	815
2018 Q2	$264K	Hold	12,886	–	–	0.01%	882
2018 Q1	$234K	Buy	12,886 +68	+0.5%	+$1.13K	0.01%	919
2017 Q4	$179K	Buy	12,818 +884	+7%	+$11.9K	﹤0.01%	1014
2017 Q3	$221K	Buy	11,934 +3,638	+44%	+$60.8K	0.01%	875
2017 Q2	$140K	Buy	8,296 +4,284	+107%	+$65.2K	﹤0.01%	977
2017 Q1	$54K	Sell	4,012 -748	-16%	-$11.7K	﹤0.01%	1113
2016 Q4	$72K	Buy	+4,760	New	+$62.9K	﹤0.01%	1008

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Glen Harbor Capital Management's MNTA Position: Q3 2019 in Review

Glen Harbor Capital Management increased its Momenta Pharmaceuticals, Inc. (MNTA) stake by 3.1% in Q3 2019, buying an estimated $8.21K and bringing the position to 22,372 shares worth $290K. The position accounts for 0.01% of the portfolio, ranked #898.

Glen Harbor Capital Management first reported a position in MNTA in Q4 2016 and has held it in 12 quarters since. The position peaked at $394K in Q3 2018. 154 funds tracked by Wall St. Rank hold MNTA as of Q3 2019.

Glen Harbor Capital Management held 22,372 shares of Momenta Pharmaceuticals, Inc. worth $290K as of Q3 2019.
Glen Harbor Capital Management bought 680 Momenta Pharmaceuticals, Inc. shares in Q3 2019, an estimated $8.21K.
Momenta Pharmaceuticals, Inc. made up 0.01% of Glen Harbor Capital Management's portfolio in Q3 2019, its #898 holding.
Glen Harbor Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2016 and has held it in 12 quarters since.
Glen Harbor Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $394K in Q3 2018.
154 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.